<DOC>
	<DOCNO>NCT01343680</DOCNO>
	<brief_summary>The purpose study determine whether flush Central Venous Catheters ( CVCs ) Normal saline per week inferior flush 10U/ml heparin 3 time per week , prevent CVC occlusion .</brief_summary>
	<brief_title>Trial Two Central Venous Catheter ( CVC ) Flushing Schemes Pediatric Hematology Oncology Patients</brief_title>
	<detailed_description>Tunneled central venous catheter ( CVCs ) use routinely pediatric hematology oncology patient . Flushing heparin solution routinely recommend prevent occlusion long term CVCs , although concentration heparin use , frequency use vary centre . Once weekly Normal saline also use successfully pediatric enters . There little evidence support one method . The investigator design randomise crossover trial directly compare weekly Normal saline flush 3 time per week 10U/ml heparin flushing , determine whether Normal saline inferior heparin .</detailed_description>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Flushing</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Inclusion Criteria Diagnosis malignant nonmalignant disease require single lumen Broviac double lumen Hickmantype CVC purpose chemotherapy , blood product support hematopoietic stem cell transplantation . CVC plan remain situ 6 month study entry Thrombophilia ( e.g . Factor V Leiden mutation , antiphospholipid syndrome ) previous thrombosis require anticoagulation ( e.g . enoxaparin , unfractionated heparin ) Bleeding disorder ( e.g . von Willebrand 's disease , hemophilia ) Previous CVC remove due complication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>